Back

State of the art in therapeutic modulation of the immune response in atherosclerosis

30 August 2016 (08:30 - 08:48)
Organised by:
Congress Presentation Part of: Therapeutic modulation of the immune response in atherosclerosis Atherosclerosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Peter Libby

Mass General Brigham, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Nanoparticle-enabled RNAi in endothelial cells attenuates inflammation in atherosclerosis and acute myocardial infarction
Doctor H. Sager (Munich, DE)
Abstract
Presentation thumbnail
STAT4 deficiency exacerbates atherosclerosis by promoting mobilization of myeloid cells, polarization of M1 macrophages and formation of foam cells
Doctor L. Xu (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Bone marrow-specific Sirt6 deletion enhances atherosclerosis and foam cell formation via an increase in macrophage scavenger receptor 1 expression
Miss T. Arsiwala (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Future direction for research in therapeutic modulation of the immune response in atherosclerosis.
Professor J. Nilsson (Malmo, SE)
Slides Video

Access the full session

Session thumbnail
Therapeutic modulation of the immune response in atherosclerosis

The Event

Event poster

ESC Congress 2016

30 August 2016 08:30 CET
You may be interested in
thumbnail
Webinar
Recent advances in immune pathways in atherosclerosis
21 April 2021
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025
thumbnail
Congress Presentation
Atorvastatin-preconditioned HUMSC attenuate atherosclerosis via exosomes transfer of hsa-miR-454-3p targeting IRF1/NF-kB to modulate macrophage polarization
29 August 2025
thumbnail
Congress Presentation
Immune-related cardiovascular adverse events in a real-world cohort of patients treated with immune checkpoint inhibitors
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources